Rachel joined NPEU in 2017 as the NeoCLEAR Trial Manager. She has previously managed surgical and orthopaedic trials within the University of Oxford, and coordinated patient pathways and acute care services within the NHS.
Building a relationship with industry - An academic’s experience working with Zimmer Biomet Cushla Cooper1, Rachel Dorman1, David Beard1 , Jing Xie2 , Andrew Price1
1 University of Oxford; 2 Zimmer Biomet; Trials 2017, 18(Suppl 1):P282
Champagne and bloody taps: can we improve the success rate of neonatal lumbar punctures?Marshall A., Sadarangani M., Scrivens A., Williams R. et al Infant 2018;14(6): 224-26
Study protocol: NeoCLEAR: Neonatal Champagne Lumbar punctures Every time – An RCT: a multicentre, randomised controlled 2 × 2 factorial trial to investigate techniques to increase lumbar puncture success. Marshall, A.S.J., Sadarangani, M., Scrivens, A., Williams Ret al.BMC Pediatr20, 165 (2020). https://doi.org/10.1186/s12887-020-02050-8